Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Teva Pharmaceutical Industries (TEVJF) Assets Average (2016 - 2025)

Historic Assets Average for Teva Pharmaceutical Industries (TEVJF) over the last 17 years, with Q4 2025 value amounting to $40.3 billion.

  • Teva Pharmaceutical Industries' Assets Average fell 59.2% to $40.3 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $40.3 billion, marking a year-over-year decrease of 59.2%. This contributed to the annual value of $40.0 billion for FY2025, which is 329.81% down from last year.
  • According to the latest figures from Q4 2025, Teva Pharmaceutical Industries' Assets Average is $40.3 billion, which was down 59.2% from $40.0 billion recorded in Q3 2025.
  • Teva Pharmaceutical Industries' 5-year Assets Average high stood at $49.8 billion for Q1 2021, and its period low was $38.9 billion during Q1 2025.
  • Over the past 5 years, Teva Pharmaceutical Industries' median Assets Average value was $43.2 billion (recorded in 2023), while the average stood at $43.8 billion.
  • In the last 5 years, Teva Pharmaceutical Industries' Assets Average crashed by 1166.31% in 2021 and then plummeted by 59.2% in 2025.
  • Teva Pharmaceutical Industries' Assets Average (Quarter) stood at $47.8 billion in 2021, then decreased by 7.59% to $44.1 billion in 2022, then decreased by 3.05% to $42.8 billion in 2023, then decreased by 5.25% to $40.5 billion in 2024, then decreased by 0.59% to $40.3 billion in 2025.
  • Its Assets Average was $40.3 billion in Q4 2025, compared to $40.0 billion in Q3 2025 and $39.3 billion in Q2 2025.